530 related articles for article (PubMed ID: 21624561)
1. The next generation of positron emission tomography radiopharmaceuticals in oncology.
Rice SL; Roney CA; Daumar P; Lewis JS
Semin Nucl Med; 2011 Jul; 41(4):265-82. PubMed ID: 21624561
[TBL] [Abstract][Full Text] [Related]
2. Beyond 18F-FDG: Characterization of PET/CT and PET/MR Scanners for a Comprehensive Set of Positron Emitters of Growing Application--18F, 11C, 89Zr, 124I, 68Ga, and 90Y.
Soderlund AT; Chaal J; Tjio G; Totman JJ; Conti M; Townsend DW
J Nucl Med; 2015 Aug; 56(8):1285-91. PubMed ID: 26135111
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Positron Emission Tomography Imaging with Zirconium-89 Desferrioxamine B Squaramide: From Bench to Bedside.
Rudd SE; Noor A; Morgan KA; Donnelly PS
Acc Chem Res; 2024 May; 57(9):1421-1433. PubMed ID: 38666539
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography.
Miller PW; Long NJ; Vilar R; Gee AD
Angew Chem Int Ed Engl; 2008; 47(47):8998-9033. PubMed ID: 18988199
[TBL] [Abstract][Full Text] [Related]
5. Light-Driven Radiochemistry with Fluorine-18, Carbon-11 and Zirconium-89.
Lin D; Lechermann LM; Huestis MP; Marik J; Sap JBI
Angew Chem Int Ed Engl; 2024 Apr; 63(14):e202317136. PubMed ID: 38135665
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. Triaryl (Z)-olefins suitable for radiolabeling with iodine-124 or fluorine-18 radionuclides for positron emission tomography imaging of estrogen positive breast tumors.
Abdellatif KR; Velázquez CA; Huang Z; Chowdhury MA; Knaus EE
Bioorg Med Chem Lett; 2011 Feb; 21(4):1195-8. PubMed ID: 21237640
[TBL] [Abstract][Full Text] [Related]
8. What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between
Bailly C; Gouard S; Guérard F; Chalopin B; Carlier T; Faivre-Chauvet A; Remaud-Le Saëc P; Bourgeois M; Chouin N; Rbah-Vidal L; Tripier R; Haddad F; Kraeber-Bodéré F; Bodet-Milin C; Chérel M
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137758
[TBL] [Abstract][Full Text] [Related]
9. Cross-coupling reactions as valuable tool for the preparation of PET radiotracers.
Pretze M; Grosse-Gehling P; Mamat C
Molecules; 2011 Jan; 16(2):1129-65. PubMed ID: 21270732
[TBL] [Abstract][Full Text] [Related]
10. A Comprehensive Review of Non-Covalent Radiofluorination Approaches Using Aluminum [
Fersing C; Bouhlel A; Cantelli C; Garrigue P; Lisowski V; Guillet B
Molecules; 2019 Aug; 24(16):. PubMed ID: 31394799
[TBL] [Abstract][Full Text] [Related]
11. Clinical PET in oncology: not only FDG.
Nanni C; Rubello D; Al-Nahhas A; Fanti S
Nucl Med Commun; 2006 Sep; 27(9):685-8. PubMed ID: 16894321
[No Abstract] [Full Text] [Related]
12. Development of "[
Jolly D; Hopewell R; Kovacevic M; Li QY; Soucy JP; Kostikov A
Appl Radiat Isot; 2017 Mar; 121():76-81. PubMed ID: 28038410
[TBL] [Abstract][Full Text] [Related]
13. Iodine-124: a promising positron emitter for organic PET chemistry.
Koehler L; Gagnon K; McQuarrie S; Wuest F
Molecules; 2010 Apr; 15(4):2686-718. PubMed ID: 20428073
[TBL] [Abstract][Full Text] [Related]
14.
Krishnan HS; Ma L; Vasdev N; Liang SH
Chemistry; 2017 Nov; 23(62):15553-15577. PubMed ID: 28704575
[TBL] [Abstract][Full Text] [Related]
15. Chemistry for Positron Emission Tomography: Recent Advances in
Deng X; Rong J; Wang L; Vasdev N; Zhang L; Josephson L; Liang SH
Angew Chem Int Ed Engl; 2019 Feb; 58(9):2580-2605. PubMed ID: 30054961
[TBL] [Abstract][Full Text] [Related]
16. Radiolabelling of the octadentate chelators DFO* and oxoDFO* with zirconium-89 and gallium-68.
Brandt M; Cowell J; Aulsebrook ML; Gasser G; Mindt TL
J Biol Inorg Chem; 2020 Aug; 25(5):789-796. PubMed ID: 32661784
[TBL] [Abstract][Full Text] [Related]
17. The bioconjugation and radiosynthesis of 89Zr-DFO-labeled antibodies.
Zeglis BM; Lewis JS
J Vis Exp; 2015 Feb; (96):. PubMed ID: 25741890
[TBL] [Abstract][Full Text] [Related]
18. Silicon-Fluoride Acceptors (SiFA) for
Gower-Fry L; Wängler C; Bartenstein P; Beyer L; Lindner S; Jurkschat K; Wängler B; Bailey JJ; Schirrmacher R
Methods Mol Biol; 2024; 2729():29-43. PubMed ID: 38006489
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.
Niedermoser S; Chin J; Wängler C; Kostikov A; Bernard-Gauthier V; Vogler N; Soucy JP; McEwan AJ; Schirrmacher R; Wängler B
J Nucl Med; 2015 Jul; 56(7):1100-5. PubMed ID: 25977461
[TBL] [Abstract][Full Text] [Related]
20. [PET radiopharmaceuticals: novelties and new possibilities].
Környei J; Mikecz P; Tóth G
Magy Onkol; 2014 Dec; 58(4):245-50. PubMed ID: 25517442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
